Achieving the Full Potential of Immunoncology
A European Biopharmaceutical Review article featuring expert insights from ICON company MolecularMD's Marissa Pearce on Leveraging Novel Therapeutics & Diagnostic Assays, presenting her argument that, although immunotherapy is nothing new, it has much untapped potential yet to be explored.
This article has been taken from EBR - Summer 2019, Pages. 78-84. © Samedan Ltd.Download Article